Döhner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 ELN recommendations from an international expert panel. Blood. 2022;140:1345–77.

Article  PubMed  Google Scholar 

Brown PA, Shah B, Advani A, Aoun P, Boyer MW, Burke PW, et al. Acute lymphoblastic leukemia, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2021;19:1079–109.

Article  CAS  Google Scholar 

Liu H, van Besien K. Alternative donor transplantation–“mixing and matching”: the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors? Curr Hematol Malig Rep. 2015;10:1–7.

Article  PubMed  Google Scholar 

Xu L, Chen H, Chen J, Han M, Huang H, Lai Y, et al. The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology. J Hematol Oncol. 2018;11:33.

Article  PubMed  PubMed Central  Google Scholar 

Kharfan-Dabaja MA, Labopin M, Bazarbachi A, Ciceri F, Finke J, Bruno B, et al. Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT. Bone Marrow Transpl. 2021;56:2194–202.

Article  CAS  Google Scholar 

Kwon M, Bautista G, Balsalobre P, Sanchez-Ortega I, Montesinos P, Bermudez A, et al. Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML. Bone Marrow Transpl. 2017;52:1138–43.

Article  CAS  Google Scholar 

Huang F, Zeng X, Fan Z, Xu N, Yu S, Xuan L, et al. Haplo-Peripheral Blood Stem Cell Plus Cord Blood Grafts for Hematologic Malignancies Might Lead to Lower Relapse Compared with Haplo-Peripheral Blood Stem Cell Plus Bone Marrow Grafts. Transpl Cell Ther. 2022;28:849.e841–849.e848.

Article  Google Scholar 

Szabolcs P, Park KD, Reese M, Marti L, Broadwater G, Kurtzberg J. Coexistent naïve phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood. Exp Hematol. 2003;31:708–14.

Article  PubMed  Google Scholar 

Luevano M, Daryouzeh M, Alnabhan R, Querol S, Khakoo S, Madrigal A, et al. The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation. Hum Immunol. 2012;73:248–57.

Article  CAS  PubMed  Google Scholar 

Hiwarkar P, Qasim W, Ricciardelli I, Gilmour K, Quezada S, Saudemont A, et al. Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells. Blood. 2015;126:2882–91.

Article  CAS  PubMed  Google Scholar 

Zhou B, Xu M, Lu S, Liu Y, Qi L, Liu T, et al. Clinical outcomes of B cell acute lymphoblastic leukemia patients treated with haploidentical stem cells combined with umbilical cord blood transplantation. Transpl Cell Ther. 2022;28:173–e171.

Article  Google Scholar 

van Besien K, Hari P, Zhang MJ, Liu HT, Stock W, Godley L, et al. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival. Haematologica. 2016;101:634–43.

Article  PubMed  PubMed Central  Google Scholar